Kelly Lawrence W & Associates’s Eli Lilly LLY Stock Holding History

Kelly Lawrence W & Associates’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$273K	Hold	227	–	–	0.06%	72
2026 Q1	$209K	Hold	227	–	–	0.06%	79
2025 Q4	$244K	Sell	227 -20	-8%	-$19.1K	0.06%	76
2025 Q3	$189K	Hold	247	–	–	0.05%	87
2025 Q2	$193K	Hold	247	–	–	0.05%	83
2025 Q1	$204K	Hold	247	–	–	0.05%	82
2024 Q4	$191K	Hold	247	–	–	0.04%	84
2024 Q3	$219K	Hold	247	–	–	0.05%	84
2024 Q2	$224K	Hold	247	–	–	0.05%	78
2024 Q1	$193K	Hold	247	–	–	0.04%	81
2023 Q4	$144K	Hold	247	–	–	0.03%	89
2023 Q3	$133K	Hold	247	–	–	0.04%	87
2023 Q2	$112K	Sell	247 -500	-67%	-$210K	0.03%	86
2023 Q1	$257K	Buy	+747	New	+$252K	0.07%	66
2018 Q1	–	Sell	-1,250	Closed	-$106K	–	150
2017 Q4	$106K	Hold	1,250	–	–	0.02%	103
2017 Q3	$107K	Hold	1,250	–	–	0.02%	104
2017 Q2	$103K	Hold	1,250	–	–	0.02%	102
2017 Q1	$105K	Hold	1,250	–	–	0.02%	109
2016 Q4	$92K	Hold	1,250	–	–	0.02%	110
2016 Q3	$100K	Hold	1,250	–	–	0.02%	113
2016 Q2	$98K	Hold	1,250	–	–	0.02%	115
2016 Q1	$90K	Hold	1,250	–	–	0.02%	110
2015 Q4	$105K	Buy	+1,250	New	+$104K	0.02%	107

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Kelly Lawrence W & Associates's LLY Position: Q2 2026 in Review

Kelly Lawrence W & Associates held its Eli Lilly (LLY) position steady in Q2 2026 at 227 shares worth $273K. The position accounts for 0.06% of the portfolio, ranked #72.

Kelly Lawrence W & Associates first reported a position in LLY in Q4 2015 and has held it in 23 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Kelly Lawrence W & Associates held 227 shares of Eli Lilly worth $273K as of Q2 2026.
Kelly Lawrence W & Associates left its Eli Lilly share count unchanged in Q2 2026.
Eli Lilly made up 0.06% of Kelly Lawrence W & Associates's portfolio in Q2 2026, its #72 holding.
Kelly Lawrence W & Associates first reported a position in Eli Lilly in Q4 2015 and has held it in 23 quarters since.
4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Kelly Lawrence W & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.